MORAb-003
Phase 3- Indications
- Ovarian cancer
Company intelligence / Profile preview
Morphotek
Exton, Pennsylvania, United Statesmedia-us.eisai.com ↗
- Ownership
- Private
- Development stage
- Phase 3
01
Overview
Morphotek developed novel monoclonal antibodies and protein therapeutics using proprietary gene evolution technologies. The company’s MORPHODOMA® technology enabled rapid creation of high-titer cell lines for scalable manufacturing. It focused on oncology and partnered with major institutions like the National Cancer Institute to develop new antibody drugs targeting unmet needs such as pancreatic cancer. After its acquisition by Eisai Co., Ltd., Morphotek continued developing its pipeline within the parent organization.
- Therapeutic areas
- OncologyImmunologyInfectious Diseases
- Modalities
- Monoclonal antibodies (mAbs)Protein therapeuticsTumor-targeting peptides
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
National Cancer Institute (NCI)Novo NordiskPivotal BioSciencesMicromet/National Institutes of Health/Cancer Innovations Inc.
Beyond the preview
Go deeper on Morphotek.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Morphotek.